News & Updates

Show Multimedia Only

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

25 Apr 2025 by

Consuming pecans as an alternative to usual snacks may improve lipids/lipoproteins and diet quality in adults at increased risk of cardiometabolic diseases, suggests a study. However, pecan intake does not appear to have any effect on vascular health.

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

25 Apr 2025

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025 by

Significant treatment gaps persist in lipid management among individuals at very high cardiovascular risk, with up to 80 percent of patients not achieving their low-density lipoprotein cholesterol (LDL-C) goals, reports a Singapore study.

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Papillary thyroid cancer (PTC) in individuals with arterial hypertension is independently associated with a diagnosis of primary aldosteronism (PA), reports a study.

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025 by

Pacemaker implantation after transcatheter aortic valve implantation (TAVI) was associated with a significantly worse prognosis in terms of all-cause and cardiovascular (CV) mortality, according to the SwissTAVI trial presented at EHRA 2025.

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Thromboprophylaxis with low molecular weight heparin (LMWH) appears to protect against the onset of superimposed pre-eclampsia, independently from aspirin use, reports a recent study.

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

22 Apr 2025 by

In the final results of the CEASE-AF* trial, a hybrid ablation strategy outshines a catheter ablation approach for the treatment of individuals with non-paroxysmal atrial fibrillation (AF).

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

22 Apr 2025

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

21 Apr 2025 by

The first-in-class monoclonal antibody bentracimab effectively and safely reverses the antiplatelet effects of ticagrelor in patients with an indication for urgent or emergent surgery or with major bleeding in the single-arm phase III REVERSE-IT trial.

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

21 Apr 2025

AF patients under 70 years of age face increased dementia risk

20 Apr 2025 by

Atrial fibrillation (AF) carries a heightened risk of dementia, especially for those under 70 years of age, according to a European population-based study said to be the largest to date.